C.F.R. homeSearch C.F.R.
C.F.R.Title 21Chapter I—Food and Drug Administration, Department of Health and Human ServicesSubchapter H—Medical DevicesPart 876—Gastroenterology-Urology DevicesSubpart D—Prosthetic Devices

21 C.F.R. § 876.3350 (2026)

Penile inflatable implant

Edition and currency
eCFR text as of Sept. 29, 2026. The text is the edition Syfert holds; for a past event, check the version in force on that date.
Other sources
CURRENTeCFR text as of Sept. 29, 2026 cited 1995–2015 8citing cases
At a glance

Courts have cited this section in 8 opinions since 1995.

(a) Identification. A penile inflatable implant is a device that consists of two inflatable cylinders implanted in the penis, connected to a reservoir filled with radiopaque fluid implanted in the abdomen, and a subcutaneous manual pump implanted in the scrotum. When the cylinders are inflated, they provide rigidity to the penis. This device is used in the treatment of erectile impotence.

(b) Classification. Class III (premarket approval).

(c) Date premarket approval application (PMA) or notice of completion of a product development protocol (PDP) is required. A PMA or a notice of completion of a PDP is required to be filed with the Food and Drug Administration on or before July 11, 2000, for any penile inflatable implant that was in commercial distribution before May 28, 1976, or that has, on or before July 11, 2000, been found to be substantially equivalent to a penile inflatable implant that was in commercial distribution before May 28, 1976. Any other penile inflatable implant shall have an approved PMA or a declared completed PDP in effect before being placed in commercial distribution.

[48 FR 53023, Nov. 23, 1983, as amended at 52 FR 17738, May 11, 1987; 65 FR 19658, Apr. 12, 2000]
The 8 cases that cite 21 C.F.R. § 876.3350 most heavily, weighted by court and treatment. RelevanceNewestTreatment
1
YELLOWSam Feldt v. Mentor Corp., 61 F.3d 431 (5th Cir. 1995).
cites § 876.3350 1×cited by 23 cases
Vacated: 2 citing opinions add another limit ("vacated (caution)").
Where it cites § 876.3350
“Although all classes of medical devices are subject to general controls, including labeling requirements and so-called good manufacturing practices (GMPs), Class II and Class III devices are subject to additional regulations. Moreover, because Class III devices are deemed to…”
Later courts cite it for
“preemption does not depend on the route the product takes to the market, but on whether there are any specific federal requirements applicable to the device.” · 2 citing courts
2
YELLOWDuvall v. Bristol-Myers-Squibb Co., 65 F.3d 392 (4th Cir. 1995).
cites § 876.3350 3×cited by 17 cases
Vacated: 2 citing opinions add another limit ("vacated (caution)").
Where it cites § 876.3350
“21 C.F.R. § 876.3350 (1994). In order to market a Class III device, a manufacturer generally must obtain premarket approval from the FDA.”
3
GREENSpier v. Coloplast Corp., 121 F. Supp. 3d 809 (E.D. Tenn. 2015).
cites § 876.3350 1×cited by 8 cases
Where it cites § 876.3350
“See 21 C.F.R. § 876.3350 (b) (classifying all “penile inflatable implant[s]” as Class III medical devices).”
4
GREENDuvall v. Bristol-Myers-Squibb Co., 103 F.3d 324 (4th Cir. 1997).
cites § 876.3350 1×cited by 20 cases
Where it cites § 876.3350
“Premarket approval requires submission of a detailed application, including clinical data, manufacturing processes, and proposed labeling, see 21 U.”
5
GREENCatherine W. Griffin v. Medtronic, Inc., 82 F.3d 79 (4th Cir. 1996).
cites § 876.3350 1×cited by 2 cases
Where it cites § 876.3350
“3d at 396 , 21 C.F.R. § 876.3350 (1995). A manufacturer must generally receive approval from the Food and Drug Administration ("FDA") before marketing a Class III device.”
6
NEUTRALSylvester v. Mentor Corp., 663 So. 2d 176 (La. Ct. App. 1995).
cites § 876.3350 1×cited by 4 cases
Where it cites § 876.3350
“which cannot be classified as Class I or Class II devices because insufficient information exists to determine that the controls provided for Class I or Class II devices would provide reasonable assurance of the safety and effectiveness of the devices and which are represented…”
7
YELLOWFeldt v. Mentor Corp., No. 94-20592 (5th Cir. Aug. 21, 1995).
cites § 876.3350 1×cited by 0 cases
Where it cites § 876.3350
“21 C.F.R. § 876.3350 (b). Before being marketed and sold, Class III devices must undergo the rigors of Pre-Market Approval (PMA), a lengthy, comprehensive process, at the end of which the FDA determines whether there is "reasonable assurance" that the device under consideration…”
8
NO FLAGGriffin v. Medtronic Inc, No. 94-1219 (4th Cir. Apr. 30, 1996).
cites § 876.3350 1×cited by 0 cases
Where it cites § 876.3350
“3d at 396 ; 21 C.F.R. § 876.3350 (1995). A manufacturer must generally receive approval from the Food and Drug Administration ("FDA") before marketing a Class III device.”

The flag is Syfertize’s treatment of the citing case itself, not of the statute. “Where it cites” is the passage in the opinion; the holding is a summary of the whole case and may concern another point. Annotations are extracted automatically from the opinions in the Syfert caselaw corpus.

Citing cases by year
199520052015

One bar per year. Tallest: 4 cases in 1995. These are opinions in the Syfert collection, which holds more of some courts’ recent opinions than their older ones, so a rise can reflect what the collection holds and not more litigation.

By court
4th Cir.45th Cir.2La. Ct. App.1E.D. Tenn.1
By subsection

Courts have not cited this section by subsection, so its cases are not split up here. The Leading cases tab lists the cases that cite it most heavily.

Enactment and amendments

Syfert holds no separate history line for this section. Where this code prints a source or history note, it appears with the text, usually at the end.

Versions

Edition shown: eCFR text as of Sept. 29, 2026. Syfert holds no earlier or later version of this section.

C.F.R. Home  |  Search C.F.R.  |  Search cases for this section  |  syfert.com